Caption Health (Brisbane, Calif.) has raised $53 million in a Series B round as it seeks to further develop and commercialize its FDA-cleared, AI-guided ultrasound technology.

Existing investor DCVC led the round, announced yesterday. New investors Atlantic Bridge and cardiovascular medical device leader Edwards Lifesciences also participated, along with existing investor Khosla Ventures.

Caption Health touts Caption AI as the first and only AI-guided medical imaging acquisition system, allowing healthcare providers without lengthy specialized training to perform ultrasound and obtain diagnostic-quality images. The company accelerated its plan to bring Caption AI to market in late summer after increased demand from clinicians caring for patients with COVID-19.